Profile data is unavailable for this security.
About the company
Cochlear Limited provides implantable hearing solutions and a range of implants and sound processor upgrades. Its segments include Cochlear Implants, Services, and Acoustics. The Cochlear Implants segment offers Cochlear implant systems. The Services segment offers sound processor upgrades, accessories and other. The Acoustics segment offers bone conduction systems and sound processor upgrades. Its products and services portfolio includes Cochlear implant portfolio, Acoustic solutions portfolio, Recipient support tools, and Cochlear Connected Care solutions. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check. Its Cochlear implant portfolio includes Cochlear Nucleus System. Acoustic solutions portfolio includes Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, and Baha and Osia Smart Apps.
- Revenue in AUD (TTM)2.34bn
- Net income in AUD345.30m
- Incorporated1983
- Employees5.50k
- LocationCochlear Ltd1 University AvenueMacquarie UniversitySYDNEY 2109AustraliaAUS
- Phone+61 29428-6555
- Fax+61 29428-6352
- Websitehttps://www.cochlear.com/sg/en/home
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APT Medical Inc | 493.35m | 157.38m | 6.89bn | 2.56k | 43.69 | 11.26 | -- | 13.97 | 5.46 | 5.46 | 17.14 | 21.20 | 0.7689 | 1.56 | 35.44 | 942,626.30 | 23.97 | 19.84 | 27.54 | 24.22 | 71.50 | 70.81 | 31.18 | 29.16 | 4.11 | -- | 0.0072 | 27.21 | 25.18 | 38.60 | 26.08 | 52.14 | 57.28 | -- |
| XtalPi Holdings Ltd | 139.99m | -40.46m | 7.56bn | 1.05k | -- | 4.91 | -- | 53.97 | -0.0681 | -0.0681 | 0.2163 | 1.98 | 0.1118 | -- | 2.45 | 960,010.20 | -3.31 | -- | -3.58 | -- | 63.91 | -- | -29.62 | -- | 9.65 | -- | 0.0495 | -- | 52.75 | -- | 20.78 | -- | -- | -- |
| ASAHI INTECC CO., LTD. | 1.16bn | 158.49m | 7.95bn | 9.47k | 50.41 | 5.62 | 32.73 | 6.83 | 66.32 | 66.32 | 482.54 | 594.65 | 0.6725 | 1.49 | 7.10 | 13,702,100.00 | 9.20 | 8.09 | 10.38 | 9.51 | 69.34 | 66.02 | 13.68 | 13.78 | 3.49 | 171.56 | 0.047 | 35.60 | 11.60 | 16.24 | -19.43 | 6.77 | -2.47 | 22.43 |
| Sysmex Corp | 4.51bn | 400.90m | 8.32bn | 10.53k | 20.54 | 1.83 | 10.34 | 1.85 | 71.78 | 71.78 | 806.72 | 803.69 | 0.7448 | 2.54 | 3.21 | 47,749,460.00 | 6.60 | 8.70 | 7.95 | 10.94 | 51.85 | 52.47 | 8.87 | 10.98 | 2.44 | 18.05 | 0.1241 | 38.11 | 10.21 | 10.99 | 8.12 | 9.00 | 13.54 | 5.92 |
| Cochlear Ltd | 2.34bn | 345.30m | 12.80bn | 5.50k | 37.16 | 6.60 | 28.86 | 5.47 | 5.27 | 5.27 | 35.67 | 29.64 | 0.8382 | 1.24 | 4.87 | 425,181.80 | 12.38 | 12.88 | 15.71 | 16.53 | 72.76 | 74.26 | 14.77 | 17.20 | 1.44 | 35.20 | 0.1111 | 68.10 | 4.81 | 12.15 | 9.00 | -- | -4.70 | 21.86 |
| Pro Medicus Ltd | 248.69m | 234.70m | 13.12bn | 132.00 | 56.02 | 33.74 | 54.13 | 52.77 | 2.24 | 2.24 | 2.38 | 3.72 | 0.6006 | 4.12 | 3.77 | 1,884,015.00 | 56.68 | 34.81 | 63.01 | 40.65 | 99.87 | 99.69 | 94.37 | 49.37 | 6.22 | -- | 0.0065 | 43.48 | 32.59 | 31.08 | 39.16 | 37.93 | -1.29 | 35.59 |
| Lenskart Solutions Ltd | 1.24bn | 79.29m | 14.00bn | -- | 176.25 | -- | 66.65 | 11.33 | 2.98 | 2.98 | 46.48 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 67.93 | -- | 6.45 | -- | -- | 3.63 | -- | -- | 22.57 | -- | 3,028.30 | -- | -- | -- |
| Olympus Corp | 8.85bn | 759.73m | 14.57bn | 29.30k | 19.30 | 2.08 | 10.65 | 1.65 | 75.61 | 75.63 | 882.16 | 702.36 | 0.6894 | 1.62 | 5.12 | 33,706,730.00 | 5.92 | 6.74 | 8.27 | 9.51 | 66.24 | 66.85 | 8.59 | 10.69 | 1.09 | 23.11 | 0.2352 | 21.13 | 6.53 | 5.72 | 342.69 | 14.22 | -0.2194 | 14.87 |
| Holder | Shares | % Held |
|---|---|---|
| AustralianSuper Pty Ltd.as of 13 Nov 2025 | 4.06m | 6.21% |
| State Street Global Advisors, Australia, Ltd.as of 08 Aug 2025 | 3.50m | 5.35% |
| APG Asset Management NVas of 22 Aug 2024 | 3.27m | 5.00% |
| Hyperion Asset Management Ltd.as of 10 Nov 2025 | 3.26m | 4.99% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 2.37m | 3.62% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 1.39m | 2.13% |
| First Sentier Investors (Australia) IM Ltd.as of 21 Aug 2024 | 1.37m | 2.10% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 1.30m | 1.99% |
| Vanguard Investments Australia Ltd.as of 31 Jan 2026 | 1.18m | 1.80% |
| First Sentier Investors (UK) IM Ltd.as of 21 Aug 2024 | 1.16m | 1.78% |
